Akebia Therapeutics Shares Are Trading Higher After the FDA Approved Vafseo Tablets for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
在美國食品藥品管理局批准Vafseo片劑用於治療接受透析的成年患者因慢性腎臟病引起的貧血後,Akebia Therapeutics股價走高
Akebia Therapeutics Shares Are Trading Higher After the FDA Approved Vafseo Tablets for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis
在美國食品藥品管理局批准Vafseo片劑用於治療接受透析的成年患者因慢性腎臟病引起的貧血後,Akebia Therapeutics股價走高
使用瀏覽器的分享功能,分享給你的好友吧